tiprankstipranks
Acrivon Therapeutics, Inc. (ACRV)
NASDAQ:ACRV
US Market
ACRV
Acrivon Therapeutics, Inc.
RESEARCH TOOLSreports

Acrivon Therapeutics, Inc. (ACRV) Financial Statements

835 Followers

Acrivon Therapeutics, Inc. Financial Overview

Acrivon Therapeutics, Inc.'s market cap is currently $58.89M. The company's EPS TTM is $-0.49; its P/E ratio is -1.19; Acrivon Therapeutics, Inc. is scheduled to report earnings on March 19, 2026, and the estimated EPS forecast is $-0.51. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -1.36M$ -1.01M$ -536.00K$ 0.00$ 0.00
Operating Income$ -84.11M$ -89.20M$ -67.24M$ -32.66M$ -16.18M
EBITDA$ -82.76M$ -79.55M$ -59.85M$ -32.29M$ -16.15M
Net Income$ -77.91M$ -80.56M$ -60.39M$ -31.17M$ -16.24M
Balance Sheet
Cash & Short-Term Investments$ 118.58M$ 179.48M$ 127.46M$ 127.75M$ 99.60M
Total Assets$ 129.72M$ 196.59M$ 138.26M$ 181.23M$ 106.59M
Total Debt$ 2.71M$ 3.65M$ 4.64M$ 4.96M$ 5.63M
Net Debt$ -38.79M$ -36.17M$ -31.37M$ -24.56M$ -93.97M
Total Liabilities$ 17.20M$ 19.80M$ 17.07M$ 10.75M$ 130.40M
Stockholders' Equity$ 112.52M$ 176.79M$ 121.19M$ 170.47M$ -23.81M
Cash Flow
Free Cash Flow$ -65.33M$ -68.44M$ -43.93M$ -32.28M$ -14.22M
Operating Cash Flow$ -63.66M$ -65.67M$ -42.64M$ -30.12M$ -13.98M
Investing Cash Flow$ 66.10M$ -51.77M$ 50.72M$ -141.68M$ -238.00K
Financing Cash Flow$ -749.00K$ 121.03M$ -1.55M$ 101.71M$ 112.22M
Currency in USD

Acrivon Therapeutics, Inc. Earnings and Revenue History

Income Statement >

Acrivon Therapeutics, Inc. Debt to Assets

Balance Sheet >

Acrivon Therapeutics, Inc. Cash Flow

Cash Flow >

Acrivon Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >